BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
61 results:

  • 1. TUMOR MARKERS EXPRESSION LEVELS IN gastric cancer PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
    Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
    Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
    Wyrwicz L; Rodríguez Sánchez CA; Sánchez-Rovira P; Lewis S; Sandschafer D; San T
    Future Oncol; 2024 Apr; 20(13):821-832. PubMed ID: 38305004
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
    McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
    J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Antral plexiform fibromyxoma: case report of a rare mesenchymal neoplasm.
    Oliveira Dos Santos CE; Malaman D; Arciniegas Sanmartin ID; Aleixo P; Lopes CV; Pereira-Lima JC
    Rev Gastroenterol Peru; 2023; 43(4):364-367. PubMed ID: 38228303
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New developments and standard of care in the management of advanced gastric cancer.
    Depotte L; Palle J; Rasola C; Broudin C; Afrăsânie VA; Mariani A; Zaanan A
    Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102245. PubMed ID: 37952913
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
    J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
    Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
    Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer.
    Sur D; Lungulescu C; Dumitrescu EA; Afrăsânie V; Spînu Ș; Lungulescu CV; Schmoll HJ
    Expert Rev Anticancer Ther; 2023 Jun; 23(6):633-641. PubMed ID: 37127555
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.
    Sugimoto R; Uesugi N; Yamada N; Osakabe M; Baba S; Yanagawa N; Akiyama Y; Habano W; Sasaki A; Oda Y; Sugai T
    Diagn Pathol; 2023 Feb; 18(1):24. PubMed ID: 36803776
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
    Chen K; Xu J; Tong YL; Yan JF; Pan Y; Wang WJ; Zheng L; Zheng XX; Hu C; Hu X; Shen X; Chen W
    Cell Death Dis; 2023 Feb; 14(2):115. PubMed ID: 36781842
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 12.
    Radziejewska I; Supruniuk K; Tomczyk M; Izdebska W; Borzym-Kluczyk M; Bielawska A; Bielawski K; Galicka A
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955735
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer.
    Liu P; Chen J; Zhao L; Hollebecque A; Kepp O; Zitvogel L; Kroemer G
    Oncoimmunology; 2022; 11(1):2093518. PubMed ID: 35769948
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Trifluridine/tipiracil in the treatment of gastric cancer.
    Fostea RM; Arkenau HT
    Future Oncol; 2022 Apr; 18(12):1511-1517. PubMed ID: 35081748
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [A Case of Spindle Cell Tumor in the gastric Mucosa Treated with Laparoscopic Local Gastrectomy].
    Tamai H; Kobayashi S; Suzuki H; Hatakeyama T; Sakai K; Komiyama S; Ogino S; Akami T; Ueda Y; Mazaki T
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2055-2057. PubMed ID: 35045491
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pathological diagnosis, differential diagnosis and origin investigation of easily misdiagnosed adult gastric duplication cysts.
    Liu F; Zhao H
    Histol Histopathol; 2022 Feb; 37(2):181-188. PubMed ID: 34964481
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anti-cancer effect of combined action of anti-muc1 and rosmarinic acid in AGS gastric cancer cells.
    Radziejewska I; Supruniuk K; Bielawska A
    Eur J Pharmacol; 2021 Jul; 902():174119. PubMed ID: 33930385
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Randomized Controlled Trial of the Gastrin/CCK
    Abrams JA; Del Portillo A; Hills C; Compres G; Friedman RA; Cheng B; Poneros J; Lightdale CJ; De La Rue R; di Pietro M; Fitzgerald RC; Sepulveda A; Wang TC
    Cancer Prev Res (Phila); 2021 Jun; 14(6):675-682. PubMed ID: 33782049
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressing gastric cancer model.
    Bali P; Lozano-Pope I; Pachow C; Obonyo M
    Int J Oncol; 2021 Mar; 58(3):388-396. PubMed ID: 33469673
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.
    Jacqueline C; Lee A; Frey N; Minden JS; Finn OJ
    Cancer Immunol Res; 2020 Aug; 8(8):1027-1038. PubMed ID: 32467324
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.